Hi Chilunsin
Agree with all you say and like i have said previously under normal circumstances ref takeover you would be on the money
However the way this trial is going to pan out from here and now
Its a case of all or nothing for the big Pharmas
because post trial if successful were going to market, when under normal circumstances we would be looking for multi million dollars to fund a PH3 before going to market at which time a pharma would step in to take the trials forwards
Personally i would like them to split the rights as Sarepta did
We take it through Europe and the pharma take it through the FDA
But they would have to, for mine be speaking the numbers that Roche paid up placebo or no placebo cash or no cash at bank, that is now a bench mark and carries a failure taboot
and their lies the the conundrum if they are talking those types of figures they will just take the farm not acreage
The alternative is we raise big time and dont worry about dilution and go it alone because if the trial is a success it wont matter
see how we go
- Forums
- ASX - By Stock
- PER
- Ann: Quarterly Update and Appendix 4C
Ann: Quarterly Update and Appendix 4C, page-31
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
-0.002(2.44%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 8.0¢ | $3.675K | 45.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 343 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 343 | 0.080 |
1 | 24999 | 0.079 |
3 | 78158 | 0.078 |
1 | 13844 | 0.077 |
1 | 8000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 10000 | 1 |
0.083 | 281992 | 3 |
0.084 | 100000 | 1 |
0.085 | 136669 | 3 |
0.086 | 135412 | 3 |
Last trade - 14.33pm 09/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |